Related Experiment Video
Updated: Jan 18, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
cGAS-STING signaling pathway in MASLD and liver fibrosis
Abstract:
In metabolic dysfunction-associated steatotic liver disease (MASLD), lipid accumulation and inflammatory stimulation lead to the release of damage-associated molecular patterns, thereby inducing the activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway. The cGAS-STING signaling pathway in the liver is primarily activated in Kupffer cells/macrophages, hepatic stellate cells, hepatocytes and liver sinusoidal endothelial cells. Emerging evidence also reveals that the cGAS-STING signaling pathway contributes to liver cell fate changes in MASLD. Herein, this review summarizes the role of the cGAS-STING signaling pathway in liver cells and its effect on cell fate in the context of MASLD and liver fibrosis. Therapeutic agents targeting the cGAS-STING signaling pathway may shed light on the clinical treatment of MASLD and liver fibrosis.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
The JAK-STAT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
TGF - β Signaling Pathway